LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.04 27.76 388 5365 0.0723 0.4152
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.04 27.76 4534 5365 0.8450 0.9561
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.04 27.76 1899 5365 0.3539 0.7444
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.04 27.76 3851 5365 0.7177 0.9145
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 54.74 27.76 410 5606 0.0731 0.4214
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 54.74 27.76 4742 5606 0.8458 0.9567
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 54.74 27.76 2031 5606 0.3623 0.7516
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 54.74 27.76 4040 5606 0.7206 0.9162
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 56.45 27.76 467 5745 0.0813 0.4433
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 56.45 27.76 4984 5745 0.8675 0.9634
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 56.45 27.76 2041 5745 0.3552 0.7483
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 56.45 27.76 4197 5745 0.7305 0.9200
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.15 27.76 484 5906 0.0819 0.4472
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.15 27.76 5213 5906 0.8826 0.9680
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.15 27.76 2139 5906 0.3621 0.7538
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.15 27.76 4400 5906 0.7449 0.9253
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 59.85 27.76 515 6062 0.0849 0.4562
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 59.85 27.76 5453 6062 0.8994 0.9729
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 59.85 27.76 2268 6062 0.3741 0.7623
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 59.85 27.76 4604 6062 0.7594 0.9304
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 61.56 27.76 559 6217 0.0899 0.4690
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 61.56 27.76 5609 6217 0.9022 0.9738
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 61.56 27.76 2236 6217 0.3597 0.7545
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 61.56 27.76 4782 6217 0.7692 0.9339
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 63.26 27.76 2925 6465 0.4524 0.8081
MN20160318_Q01
C19